Daily Archives: May 22, 2021

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and tissues with the help of specific processes. Doing this may involve a partial or complete reengineering of human cells so that they start to function normally.

Regenerative medicine also involves the attempts to grow tissues and organs in a laboratory environment, wherein they can be put in a body that cannot heal a particular part. Such implants are mainly preferred to be derived from the patients own tissues and cells, particularly stem cells. Looking at the promising nature of stem cells to heal and regenerative various parts of the body, this field is certainly expected to see a bright future. Doing this can help avoid opting for organ donation, thus saving costs. Some healthcare centers might showcase a shortage of organ donations, and this is where tissues regenerated using patients own cells are highly helpful.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1889

There are several source materials from which regeneration can be facilitated. Extracellular matrix materials are commonly used source substances all over the globe. They are mainly used for reconstructive surgery, chronic wound healing, and orthopedic surgeries. In recent times, these materials have also been used in heart surgeries, specifically aimed at repairing damaged portions.

Cells derived from the umbilical cord also have the potential to be used as source material for bringing about regeneration in a patient. A vast research has also been conducted in this context. Treatment of diabetes, organ failure, and other chronic diseases is highly possible by using cord blood cells. Apart from these cells, Whartons jelly and cord lining have also been shortlisted as possible sources for mesenchymal stem cells. Extensive research has conducted to study how these cells can be used to treat lung diseases, lung injury, leukemia, liver diseases, diabetes, and immunity-based disorders, among others.

Global Regenerative Medicine Market: Overview

The global market for regenerative medicine market is expected to grow at a significant pace throughout the forecast period. The rising preference of patients for personalized medicines and the advancements in technology are estimated to accelerate the growth of the global regenerative medicine market in the next few years. As a result, this market is likely to witness a healthy growth and attract a large number of players in the next few years. The development of novel regenerative medicine is estimated to benefit the key players and supplement the markets growth in the near future.

Global Regenerative Medicine Market: Key Trends

The rising prevalence of chronic diseases and the rising focus on cell therapy products are the key factors that are estimated to fuel the growth of the global regenerative medicine market in the next few years. In addition, the increasing funding by government bodies and development of new and innovative products are anticipated to supplement the growth of the overall market in the next few years.

Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=1889&ltype=S

On the flip side, the ethical challenges in the stem cell research are likely to restrict the growth of the global regenerative medicine market throughout the forecast period. In addition, the stringent regulatory rules and regulations are predicted to impact the approvals of new products, thus hampering the growth of the overall market in the near future.

Global Regenerative Medicine Market: Market Potential

The growing demand for organ transplantation across the globe is anticipated to boost the demand for regenerative medicines in the next few years. In addition, the rapid growth in the geriatric population and the significant rise in the global healthcare expenditure is predicted to encourage the growth of the market. The presence of a strong pipeline is likely to contribute towards the markets growth in the near future.

Global Regenerative Medicine Market: Regional Outlook

In the past few years, North America led the global regenerative medicine market and is likely to remain in the topmost position throughout the forecast period. This region is expected to account for a massive share of the global market, owing to the rising prevalence of cancer, cardiac diseases, and autoimmunity. In addition, the rising demand for regenerative medicines from the U.S. and the rising government funding are some of the other key aspects that are likely to fuel the growth of the North America market in the near future.

Furthermore, Asia Pacific is expected to register a substantial growth rate in the next few years. The high growth of this region can be attributed to the availability of funding for research and the development of research centers. In addition, the increasing contribution from India, China, and Japan is likely to supplement the growth of the market in the near future.

Global Regenerative Medicine Market: Competitive Analysis

The global market for regenerative medicines is extremely fragmented and competitive in nature, thanks to the presence of a large number of players operating in it. In order to gain a competitive edge in the global market, the key players in the market are focusing on technological developments and research and development activities. In addition, the rising number of mergers and acquisitions and collaborations is likely to benefit the prominent players in the market and encourage the overall growth in the next few years.

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1889

Some of the key players operating in the regenerative medicine market across the globe are Vericel Corporation, Japan Tissue Engineering Co., Ltd., Stryker Corporation, Acelity L.P. Inc. (KCI Licensing), Organogenesis Inc., Medtronic PLC, Cook Biotech Incorporated, Osiris Therapeutics, Inc., Integra Lifesciences Corporation, and Nuvasive, Inc. A large number of players are anticipated to enter the global market throughout the forecast period.

Related Market Reports:

https://www.tmrresearch.com/personalized-medicine-market

https://www.tmrresearch.com/alternative-complementary-medicine-market

https://www.tmrresearch.com/herbal-medicine-market

READ EXCLUSIVE PRESS RELEASES AND ARTICLES: https://tmrresearchblog.com/

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/

Go here to see the original:

Regenerative Medicine Market - Increasing Demand of Personalized Medicines and the Advancements in Technology Drive the Market | TMR Research Study -...

My hope is that sharing my journey will open a dialogue about mental health for millions of people. - Lamar Odom

Lamar Odom Reborn Official Trailer

As a public figure, Odom's challenges with addiction are well-documented, but what is lesser known are the deep-rooted pain and trauma he endured with the loss of his mother as a child and then untimely loss of his own son, Jaden, at just six month old. Lamar admits he self-medicated and avoided professional interventions given the stigma attached with mental health treatment.

"Admitting you are depressed or asking for help is a challenge for anyone," says Odom. "My hope is that sharing my journey in Reborn will open a dialogue for millions of people. The alternative medicines I explore in the film changed my life, giving me the power and strength to make better choices, repair relationships, and break unhealthy patterns. Just months after my first ketamine and ibogaine treatments, I felt physically well enough to play professional basketball again."

"While ibogaine is legal in other countries, it is not available in the United States, yet," says Zappy Zapolin, director of Reborn and psychedelic concierge to the stars. "Ketamine, however, is an FDA-approved anesthetic that has been hailed as a miracle for treating depression, anxiety, PTSD, addiction, and more. Research at Yale School of Medicine has shown that a single dose of ketamine can rapidly reverse stress-induced damage to brain cell connections."

"Zappy and I have been touting the benefits of medical ketamine therapy for several years now," says Warren Gumpel, Producer of Reborn. "As co-founders of the non-profit The Ketamine Fund,we have been able to donate over 500 free, medically-supervised ketamine treatments to veterans suffering from PTSD, substantially reducing their depression and suicidal ideation."

Today, Lamar continues to support his mental health with at-home ketamine treatments through a company called KetaMD, the evolution of The Ketamine Fund project, also founded by Zappy Zapolin and Warren Gumpel. Currently in beta, the duo founded KetaMD to provide affordable and accessible at-home medical ketamine treatments to the millions of Americans who are suffering from anxiety, depression, PTSD, and suicidal thoughts. To learn more, please visit http://www.KetaMD.com.

Lamar Odom Rebornwill be released on May 20, 2021 on All Def's YouTube channel for "Mental Health Action Day," in partnership with MTV Entertainment Group. There will also be a global viewing event with Lamar and the filmmakers on May 22, 2021 on Facebook at Facebook.com/Unify at 2 pm PT/5 pm ET.

Please visit http://www.LamarOdomReborn.comfor all details and multiple free streaming options.

Instagram

Facebook

For media inquiries, please contact Kimberly Angell of Wish Public Relations at kim dot angell at wishpr dot com.

About Lamar Odom Reborn

Rebornhighlights Lamar's journey, guided by psychedelic concierge and film director Zappy Zapolin, as he implements therapies such as ketamine, ibogaine, plant medicines, and daily practices. His brave healing journey role models a powerful path of evolution, towards a life that is truly worth living.

SOURCE Zappy Zapolin

Link:

Lamar Odom Reborn: New Documentary Follows NBA Athlete's Journey to Beat Addiction and Anxiety Through the Use of Psychedelic Medicines - PRNewswire

DUBLIN--(BUSINESS WIRE)--The "Global Cell Therapy Market By Therapy Type, By Therapeutic Area, By End User, By Cell Type, By Regional Outlook, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

The Global Cell Therapy Market size is expected to reach $28.5 billion by 2026, rising at a market growth of 26.2% CAGR during the forecast period.

Cell therapy is considered as a technology that is based on substituting dysfunctional or diseased cells with active & functional cells. Stem cells possess the capability to differentiate into particular cells needed for repairing damaged or defective tissues or cells, that's why they are utilized for these advanced therapies.

In addition, cell therapy is used in the development of regenerative medicines, which is an interdisciplinary domain aimed at maintenance, enhancement, or restoration of cell, tissue, organ function with the help of procedures majorly associated with cell therapy.

Moreover, cells like bone marrow and blood cells, mature, immature & solid tissue cells, adult stem cells, and embryonic cells are extensively deployed in cell therapy methods. Further, transplanted cells involve embryonic stem cells (ESCs), pluripotent stem cells (iPSCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs) are bifurcated mainly two groups viz. Allogeneic cell therapy and non-Allogeneic cell therapy.

At present, there are two types of cell therapies exist. The first type is cell therapy in mainstream medicine. This category includes human embryonic stem cell therapy, mesenchymal stem cell therapy, neural stem cell therapy, Autologous cell therapy, and hematopoietic stem cell therapy. The second category is in alternative medicine and perpetuates the practice of injecting animal materials in an effort to cure diseases. This practice, as per the American Cancer Society, is not supported by any medical proof of efficiency and can have fatal results.

The outbreak of the COVID-19 pandemic has affected many biopharmaceutical units, while many cellular therapy development organizations have observed a severe impact, which is due to the complexities in logistics and manufacturing models used in this sector. Moreover, considerable and constant investment is essential to allow effective commercial translation of cell-based therapeutics, an aspect that was negatively affected in 2020, further affected the overall market growth.

Therapy Type Outlook

Based on Therapy Type, the market is segmented into Autologous and Allogeneic. The Autologous therapies segment is expected to show gradual growth due to the massive cost associated with Autologous transplants and comparatively less relapse rates. Though, development in cell banking and companies' switch towards the creation of allogenic therapy products is boosting the cell therapy market.

Therapeutic Area Outlook

Based on Therapeutic Area, the market is segmented into Malignancies, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology and Others. The Malignancies market dominated the Global Cell Therapy Market by Therapeutic Area 2019, growing at a CAGR of 25.2 % during the forecast period. The Autoimmune Disorders market is experiencing a CAGR of 27.6% during (2020 - 2026). Additionally, The Musculoskeletal Disorders market is expected to showcase a CAGR of 27.2% during (2020 - 2026).

End User Outlook

Based on End User, the market is segmented into Academic & Research Institutes and Hospitals & Clinics. In 2019, the Academic & Research Institutes segment emerged as the leading segment of the market and held the highest revenue share. The stem cells are significantly being utilized for research projects, which as a result, has contributed to a massive revenue share for the Academic & Research Institutes segment. The segment is expected to show a similar trend during the forecast period.

Cell Type Outlook

Based on Cell Type, the market is segmented into Stem Cell, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Non-Stem Cell, Bone Marrow, Blood and Others. The Stem Cell market dominated the Global Cell Therapy Market by Cell Type 2019, and is expected to continue to be a dominant market till 2026. The Umbilical Cord-Derived market is expected to witness a CAGR of 27.7% during (2020 - 2026).

Competitive Landscape

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Fujifilm Holdings Corporation is the major forerunner in the Cell Therapy Market. Companies such as JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., Medipost Co., Ltd., Vericel Corporation, and Avantor, Inc. are some of the key innovators in the market.

Key companies profiled in the report include Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Therapy Type

By Therapeutic Area

By End User

By Cell Type

By Geography

Companies Profiled

For more information about this report visit https://www.researchandmarkets.com/r/1es4xk

See more here:

Global Cell Therapy Market Report 2021 Featuring Key Innovators Such as JCR Pharmaceuticals, NuVasive, Medipost, Vericel, and Avantor - Market to...

Actor Sonu Sood on Wednesday raised his concern over doctors recommending an injection or medicine despite it being unavailable. Taking to Twitter, he shared a post asking doctors if a substitute can be prescribed that will also help save a life.

Sonu tweeted, "One simple question: When everyone knows a particular injection is not available anywhere, why does every doctor recommends that injection only? When the hospitals cannot get that medicine then how will a common man get? Why can't v use a substitute of that medicine &save a life?"

His fans and followers reacted to the post. One wrote, "Yess , You're right Remdesvir can be substituted but Amphotericin B cannot be substituted , it's the drug of choice We'll have to do new research to develop new treatment , till then it's important." Another said, "Absolutely agree with you however it might be possible that all alternative medicines are in shortage condition now. But yes Doctor can always suggest few names with same chemical composition instead of same brand. Boss You are like a bright sunflower. Keep it up.#SaveLife" A third wrote, "@SonuSood Sir, The medicine will become scarce when demand rises and supply falls. Consequently, opening doors to more black marketing and fake medicines. Legit substitutes are must same like different covid variants."

Confederation of All India Traders (CAIT) national secretary Sumit Agarwal tweeted, "Some medicines do NOT have an alternative. If youre referring to Liposomal amphotericin B, it has no known alternative as of now. They can only prescribe what medical science has created for them. It is the systems responsibility to ensure medicines are available not doctors."

Recently, Sonu responded after the Twitter account of Ganjam district magistrate and collector had said that his foundation didn't contact them to arrange a bed for a person who was in need, adding that it took credit for the same. Sonu then provided WhatsApp conversation screenshots with a person who was looking for an oxygen bed.

Also Read: Anil Kapoor wishes wife Sunita on wedding anniversary with unseen family pics

Sonu, since last year has been providing aid to those affected by the Covid-19 pandemic. In an interview in 2020, he had told SpotboyE, I am not really going out of my way to justify my behaviour to people who doubt my intentions. To be negative is in their DNA. Its not their fault. All these are trolls. They have no spine and they are only seeking attention.

ott:10

PUBLISHED ON MAY 19, 2021 01:33 PM IST

PUBLISHED ON APR 23, 2021 07:25 AM IST

More:

Sonu Sood asks why are doctors recommending unavailable medicines to patients: 'How will a common man get them?' - Hindustan Times

ROCKAWAY, N.J.--(BUSINESS WIRE)--National Military Appreciation Month commemorates and expresses gratitude for the sacrifices current and former members of the U.S. armed forces have made for our countrys freedom. electroCore, Inc., a commercial-stage bioelectronic medicine company, is dedicated to the advancement and accessibility of healthcare solutions for veterans and hopes this important commemorative month will keep the health and treatment of military personnel top of mind.

As a result of their service, our veterans experience health challenges unique to their demographic such as burn pit exposure, post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI), says Peter Staats, MD, Chief Medical Officer of electroCore and Chief Medical Officer at the National Spine and Pain Centers. These ailments can lead to lifelong pain. In fact, a staggering 92% of military personnel are silently suffering from associated symptoms connected with TBI such as chronic headache, cluster headache, post-traumatic headache, and migraine.

electroCore has found success in preventing and treating migraine and cluster headache in the veteran community through its non-drug, non-invasive vagus nerve stimulation (nVNS) device, gammaCore SapphireTM, which has received 510(k) clearance from the FDA. The vagus nerve serves as the communication superhighway carrying information between the brain and internal organs and has a direct role in regulating pain in the human body. When the vagus nerve is electrically stimulated via nVNS, it can prevent and provide relief from migraines and cluster headaches.

Migraine, cluster headache, and other headache conditions can severely disrupt work, activities, or time spent with friends and family, becoming an overall impairment to daily living, says Sara Sacco, MD, Neurologist with the Carolinas Headache Clinic who often treats veterans within the Charlotte, North Carolina region. As a headache specialist, I make it a top priority to guide veterans to the appropriate avenue of treatment for these disabling conditions and give them the tools to help them reclaim their lives. I encourage all veterans to ask providers and learn more about non-pharmaceutical, alternative treatments, including non-invasive vagus nerve stimulation for migraine and cluster headache, and seek the treatment they deserve and put the control back into their hands."

gammaCore Sapphire is available through the VA and in military treatment facilities at no charge to patients through Federal Supply Schedule (FSS) eligible entities which covers over nine million veterans and active military personnel. With access to this treatment, veterans have already seen positive results in preventing and treating cluster headache and migraine.

Jess Ayers served almost a decade in the Navy, including tours on two submarines, and was also a part of Operation Deep Freeze. 23 years following retirement, injuries from an accident while rebuilding an air force runway led him down the dark road of migraine.

Its just been headache after headache, says Jess. The light bothers me. Its a stabbing pain on the left or right side of my head, like someone is sticking a poker through my eye or over my forehead. I have tension in the back of my neck and a lot of pressure, and it feels like my brain is in a vice.

With no success in using prescription drugs, he met with a new neurologist who suggested gammaCore as a possible solution.

The migraines started going away. I didnt have to wait three or four months with gammaCore. After three or four treatments, my headaches were gone, says Jess. I was able to start doing things and feel like a human being again. Its my go-to. I believe gammaCore should be available to everyone.

electroCore remains at the forefront of veteran clinical research. Currently electroCore is exploring nVNS as a potential treatment for mild TBI and PTSD alongside Atlanta VA Medical Center, one of several studies that are testament to electroCores dedication to improving the lives of veterans and active military personnel.

More doctors need to know this therapy exists and how it can help their patients for migraine and cluster headache, says Eric Liebler, Senior Vice President of Neurology at electroCore. Our team is studying other applications of nVNS therapys effectiveness such as post traumatic headache, as nVNS has the potential to change how we look at treating many diseases.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit http://www.electrocore.com.

About gammaCoreTM

gammaCoreTM (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as an adjunctive therapy to treat migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin. Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without the potential side effects associated with commonly prescribed drugs. When placed on a patients neck over the vagus nerve, gammaCore stimulates the nerves afferent fibers, which may lead to a reduction of pain in patients.

gammaCore is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients. gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache (Migraine, Cluster Headache, Trigeminal Autonomic Cephalalgias and Hemicrania Continua) and Medication Overuse Headache in adults.

gammaCore is contraindicated for patients if they:

Safety and efficacy of gammaCore have not been evaluated in the following patients:

Read more here:

electroCore, Inc. Celebrates Veterans and Active Members of the Military During National Military Appreciation Month - Business Wire

"I decided thatI would do everything in my power to thrive in life, in spite of the looming expiration date I'd been given. I learned how to treat myself with absolute kindness & self-respect. I radicalised my diet. I systematically detoxifiedmy body - and mind."

Jess was a devotee of Gerson therapy, a food-based protocol that claims to cure all kinds of serious ailments, most famously cancer, with an all vegetariandiet and a strict regime of fruit and vegetable juices and coffee enemas.

Sydney GP and author of the book 'Fake Medicine', Dr Brad McKay, says during her treatment, Jess Ainscough built a profile while promoting her belief that food was medicine.

In Mamamia's Extraordinary Storiespodcast on MPlus, McKay spoke to host Emma Gillespie about what Gerson therapy entails.

"Gerson therapy has been a therapy that's been around for many, many years - even from the 60s and 70s. It's a treatment that involves doing lots and lots of juices - so fresh vegetables and fruit, putting them into a big juicer. And it's quite onerous,because you have to have the juice on the hour, every hour, every day for a long time," he said.

"It also involves using enemas, that usually either contain coffee or castor oil. And again, you need to be doing these enemas a couple of times a day at least with the whole principle that you're trying to rid your body of toxins that could be sittingin your lower intestine and evacuating them.

"It hasn't been proven to work, and there are practitioners around the world that still do it. But certainly it's not recommended in Australia."

Despite there being no scientific evidence that Gerson therapy cures cancer, Jess persisted.

She started a website, wrote books, appeared on television and attracted tens of thousands of social media followers, influencing many, many people throughout her journey.

Over seven years, Jess became a media figure in Australia, and a major proponent of "natural health". She was young, likable and media-savvy.

It started out as a personal journal online and attracted a worldwide family craving this information, she told Fairfax of her blog following.

Jess had built a wellness empire.

Follow this link:

Jess Ainscough was Australias first alternative medicine influencer. Her story ended tragically. - Mamamia